Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes
Open Access
- 1 August 1998
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 41 (8) , 1420-1427
- https://doi.org/10.1002/1529-0131(199808)41:8<1420::aid-art11>3.0.co;2-u
Abstract
Objective To investigate the effect of human monoclonal anticardiolipin antibodies (aCL) on platelet interaction with the subendothelium under flow conditions and on tissue factor (TF) expression on normal monocytes. Methods Three monoclonal IgM aCL (TM1B3, GR1D5, and EY2C9) and 2 affinity‐purified IgM aCL were studied. Immunoglobulins were added to normal blood and perfused through chambers containing denuded vascular segments. Platelet interactions were morphometrically evaluated by determining the percentage of total surface covered by platelets (PCS) or by large aggregates of thrombi platelets (TP). Expression of TF on monocytes was measured after immunoglobulin incubation with normal mononuclear cells. Results Significant increases in the total PCS and expression of TF were observed using all aCL. Increased levels of TP were induced by all aCL except EY2C9 (obtained from a patient without thrombosis). Previous incubations of these aCL with subendothelial surfaces did not increase platelet interaction. Conclusion The effects of aCL on platelet function may help to explain the pathophysiology of thrombosis in the antiphospholipid syndrome.Keywords
This publication has 42 references indexed in Scilit:
- Immunology of the antiphospholipid antibody syndromeArthritis & Rheumatism, 1996
- Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosusLupus, 1996
- Procoagulant Human Monocytes Mediate Tissue Factor/Factor VIIa–Dependent Platelet-Thrombus Formation When Exposed to Flowing Nonanticoagulated Human BloodArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosusAmerican Journal of Hematology, 1991
- The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosusBritish Journal of Haematology, 1991
- Increased thromboxane formation in patients with antiphospholipid syndromeEuropean Journal of Clinical Investigation, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Effects of the Lupus Anticoagulant in Patients with Systemic lupus Erythematosus on Endothelial Cell Prostacyclin Release and Procoagulant ActivityJournal of Investigative Dermatology, 1988
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964